Table 5 Antimicrobial resistance patterns among ESBL-E isolates
ESBL-E isolates | Gentamicin, n (%) | Aztreonam, n (%) | Sulphamethoxazole-trimethoprim, n (%) | Meropenem, n (%) | Ciprofloxacin, n (%) |
|---|---|---|---|---|---|
E. coli (N = 104) | 1 (25.0) | 89 (85.6) | 79 (76.0) | 31 (29.8) | 24 (23.1) |
K. pneumoniae (N = 11) | 4 (36.4) | 10 (90.9) | 7 (63.6) | 3 (27.3) | 1 (9.1) |
K. oxytoca (N = 4) | 18 (17.3) | 3 (75.0) | 3 (75.0) | 3 (75.0) | 1 (25.0) |
Enterobacter spp. (N = 2) | 0 | 1 (50) | 2 (100.0) | 0 | 0 |
Citrobacter spp. (N = 2) | 0 | 2 (100.0) | 1 (50) | 0 | 0 |